Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Operating Leases (2019 - 2023)

Amn Healthcare Services' Operating Leases history spans 5 years, with the latest figure at $22.7 million for Q2 2023.

  • For Q2 2023, Operating Leases rose 81.91% year-over-year to $22.7 million; the TTM value through Jun 2023 reached $22.7 million, up 81.91%, while the annual FY2022 figure was $17.4 million, 30.57% up from the prior year.
  • Operating Leases reached $22.7 million in Q2 2023 per AMN's latest filing, up from $17.4 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $99.9 million in Q1 2019 to a low of $10.8 million in Q3 2022.
  • Average Operating Leases over 5 years is $55.0 million, with a median of $72.7 million recorded in 2021.
  • Peak YoY movement for Operating Leases: crashed 83.78% in 2022, then surged 81.91% in 2023.
  • A 5-year view of Operating Leases shows it stood at $91.2 million in 2019, then fell by 14.7% to $77.8 million in 2020, then plummeted by 82.82% to $13.4 million in 2021, then soared by 30.57% to $17.4 million in 2022, then skyrocketed by 30.16% to $22.7 million in 2023.
  • Per Business Quant, the three most recent readings for AMN's Operating Leases are $22.7 million (Q2 2023), $17.4 million (Q4 2022), and $10.8 million (Q3 2022).